BCL2L11 and cancer: Consistent with these observations, analysis of reverse-phase-protein-array (RPPA) data of several hundred cell lines indicated that, with few exceptions, TERT promoter mutant cancer types maintain below average levels of endogenous BIM protein expression relative to cancers lacking mutant TERT promoter (Supplementary Fig S2a and b in S1 File).